The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2007, 179, 4053 -4064
Copyright © 2007 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Allingham, M. J.
Right arrow Articles by Burridge, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Allingham, M. J.
Right arrow Articles by Burridge, K.

ICAM-1-Mediated, Src- and Pyk2-Dependent Vascular Endothelial Cadherin Tyrosine Phosphorylation Is Required for Leukocyte Transendothelial Migration1

Michael J. Allingham2, Jaap D. van Buul3 and Keith Burridge

Department of Cell and Developmental Biology, and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599

Leukocyte transendothelial migration (TEM) has been modeled as a multistep process beginning with rolling adhesion, followed by firm adhesion, and ending with either transcellular or paracellular passage of the leukocyte across the endothelial monolayer. In the case of paracellular TEM, endothelial cell (EC) junctions are transiently disassembled to allow passage of leukocytes. Numerous lines of evidence demonstrate that tyrosine phosphorylation of adherens junction proteins, such as vascular endothelial cadherin (VE-cadherin) and beta-catenin, correlates with the disassembly of junctions. However, the role of tyrosine phosphorylation in the regulation of junctions during leukocyte TEM is not completely understood. Using human leukocytes and EC, we show that ICAM-1 engagement leads to activation of two tyrosine kinases, Src and Pyk2. Using phospho-specific Abs, we show that engagement of ICAM-1 induces phosphorylation of VE-cadherin on tyrosines 658 and 731, which correspond to the p120-catenin and beta-catenin binding sites, respectively. These phosphorylation events require the activity of both Src and Pyk2. We find that inhibition of endothelial Src with PP2 or SU6656 blocks neutrophil transmigration (71.1 ± 3.8% and 48.6 ± 3.8% reduction, respectively), whereas inhibition of endothelial Pyk2 also results in decreased neutrophil transmigration (25.5 ± 6.0% reduction). Moreover, overexpression of the nonphosphorylatable Y658F or Y731F mutants of VE-cadherin impairs transmigration of neutrophils compared with overexpression of wild-type VE-cadherin (32.7 ± 7.1% and 38.8 ± 6.5% reduction, respectively). Our results demonstrate that engagement of ICAM-1 by leukocytes results in tyrosine phosphorylation of VE-cadherin, which is required for efficient neutrophil TEM.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by Grants HL 080166 and HL 45100 from the National Institutes of Health and a Kenan Distinguished Professorship (to K.B.). J.D.v.B. is supported by the Ter Meulen Fund, Royal Netherlands Academy of Arts and Sciences.

2 Address correspondence and reprint requests to Dr. Michael J. Allingham, 12-026 Lineberger Comprehensive Cancer Center, CB 7295 School of Medicine, University of North Carolina, Chapel Hill, NC 27599. E-mail address: michael_allingham{at}med.unc.edu

3 Current address: Department of Molecular Cell Biology, Sanquin Research and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, the Netherlands.

4 Abbreviations used in this paper: TEM, transendothelial migration; EC, endothelial cell; VE-cadherin, vascular endothelial cadherin.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
E. Monaghan-Benson and K. Burridge
The Regulation of Vascular Endothelial Growth Factor-induced Microvascular Permeability Requires Rac and Reactive Oxygen Species
J. Biol. Chem., September 18, 2009; 284(38): 25602 - 25611.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. A. Muller
Mechanisms of Transendothelial Migration of Leukocytes
Circ. Res., July 31, 2009; 105(3): 223 - 230.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Huveneers and E. H. J. Danen
Adhesion signaling - crosstalk between integrins, Src and Rho
J. Cell Sci., April 15, 2009; 122(8): 1059 - 1069.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
R. Martinelli, M. Gegg, R. Longbottom, P. Adamson, P. Turowski, and J. Greenwood
ICAM-1-mediated Endothelial Nitric Oxide Synthase Activation via Calcium and AMP-activated Protein Kinase Is Required for Transendothelial Lymphocyte Migration
Mol. Biol. Cell, February 1, 2009; 20(3): 995 - 1005.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. F. Nottebaum, G. Cagna, M. Winderlich, A. C. Gamp, R. Linnepe, C. Polaschegg, K. Filippova, R. Lyck, B. Engelhardt, O. Kamenyeva, et al.
VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF
J. Exp. Med., November 24, 2008; 205(12): 2929 - 2945.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Alcaide, G. Newton, S. Auerbach, S. Sehrawat, T. N. Mayadas, D. E. Golan, P. Yacono, P. Vincent, A. Kowalczyk, and F. W. Luscinskas
p120-Catenin regulates leukocyte transmigration through an effect on VE-cadherin phosphorylation
Blood, October 1, 2008; 112(7): 2770 - 2779.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Stefanidakis, G. Newton, W. Y. Lee, C. A. Parkos, and F. W. Luscinskas
Endothelial CD47 interaction with SIRP{gamma} is required for human T-cell transendothelial migration under shear flow conditions in vitro
Blood, August 15, 2008; 112(4): 1280 - 1289.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
E. Dejana, F. Orsenigo, and M. G. Lampugnani
The role of adherens junctions and VE-cadherin in the control of vascular permeability
J. Cell Sci., July 1, 2008; 121(13): 2115 - 2122.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. Hu, S. M. Vogel, D. E. Schwartz, A. B. Malik, and R. D. Minshall
Intercellular Adhesion Molecule-1-Dependent Neutrophil Adhesion to Endothelial Cells Induces Caveolae-Mediated Pulmonary Vascular Hyperpermeability
Circ. Res., June 20, 2008; 102(12): e120 - e131.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
S. M. Weis, S.-T. Lim, K. M. Lutu-Fuga, L. A. Barnes, X. L. Chen, J. R. Gothert, T.-L. Shen, J.-L. Guan, D. D. Schlaepfer, and D. A. Cheresh
Compensatory role for Pyk2 during angiogenesis in adult mice lacking endothelial cell FAK
J. Cell Biol., April 3, 2008; 181(1): 43 - 50.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. C. Porter, M. Falzon, and A. Hall
Polarized Localization of Epithelial CXCL11 in Chronic Obstructive Pulmonary Disease and Mechanisms of T Cell Egression
J. Immunol., February 1, 2008; 180(3): 1866 - 1877.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Vestweber
VE-Cadherin: The Major Endothelial Adhesion Molecule Controlling Cellular Junctions and Blood Vessel Formation
Arterioscler Thromb Vasc Biol, February 1, 2008; 28(2): 223 - 232.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
P. Turowski, R. Martinelli, R. Crawford, D. Wateridge, A.-P. Papageorgiou, M. G. Lampugnani, A. C. Gamp, D. Vestweber, P. Adamson, E. Dejana, et al.
Phosphorylation of vascular endothelial cadherin controls lymphocyte emigration
J. Cell Sci., January 1, 2008; 121(1): 29 - 37.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.